343 related articles for article (PubMed ID: 11102890)
1. Correlation of total VEGF mRNA and protein expression with histologic type, tumor angiogenesis, patient survival and timing of relapse in non-small-cell lung cancer.
Yuan A; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT; Yang PC
Int J Cancer; 2000 Nov; 89(6):475-83. PubMed ID: 11102890
[TBL] [Abstract][Full Text] [Related]
2. Vascular endothelial growth factor 189 mRNA isoform expression specifically correlates with tumor angiogenesis, patient survival, and postoperative relapse in non-small-cell lung cancer.
Yuan A; Yu CJ; Kuo SH; Chen WJ; Lin FY; Luh KT; Yang PC; Lee YC
J Clin Oncol; 2001 Jan; 19(2):432-41. PubMed ID: 11208836
[TBL] [Abstract][Full Text] [Related]
3. Aberrant p53 expression correlates with expression of vascular endothelial growth factor mRNA and interleukin-8 mRNA and neoangiogenesis in non-small-cell lung cancer.
Yuan A; Yu CJ; Luh KT; Kuo SH; Lee YC; Yang PC
J Clin Oncol; 2002 Feb; 20(4):900-10. PubMed ID: 11844810
[TBL] [Abstract][Full Text] [Related]
4. Total cyclooxygenase-2 mRNA levels correlate with vascular endothelial growth factor mRNA levels, tumor angiogenesis and prognosis in non-small cell lung cancer patients.
Yuan A; Yu CJ; Shun CT; Luh KT; Kuo SH; Lee YC; Yang PC
Int J Cancer; 2005 Jul; 115(4):545-55. PubMed ID: 15704107
[TBL] [Abstract][Full Text] [Related]
5. Quantification of VEGF mRNA expression in non-small cell lung cancer using a real-time quantitative reverse transcription-PCR assay and a comparison with quantitative competitive reverse transcription-PCR.
Yuan A; Yu CJ; Luh KT; Chen WJ; Lin FY; Kuo SH; Yang PC
Lab Invest; 2000 Nov; 80(11):1671-80. PubMed ID: 11092527
[TBL] [Abstract][Full Text] [Related]
6. Vascular endothelial growth factor, wild-type p53, and angiogenesis in early operable non-small cell lung cancer.
Giatromanolaki A; Koukourakis MI; Kakolyris S; Turley H; O'Byrne K; Scott PA; Pezzella F; Georgoulias V; Harris AL; Gatter KC
Clin Cancer Res; 1998 Dec; 4(12):3017-24. PubMed ID: 9865915
[TBL] [Abstract][Full Text] [Related]
7. Neoangiogenesis and p53 protein in lung cancer: their prognostic role and their relation with vascular endothelial growth factor (VEGF) expression.
Fontanini G; Vignati S; Lucchi M; Mussi A; Calcinai A; Boldrini L; Chiné S; Silvestri V; Angeletti CA; Basolo F; Bevilacqua G
Br J Cancer; 1997; 75(9):1295-301. PubMed ID: 9155049
[TBL] [Abstract][Full Text] [Related]
8. Vascular endothelial growth factor expression in stage I non-small cell lung cancer correlates with neoangiogenesis and a poor prognosis.
Han H; Silverman JF; Santucci TS; Macherey RS; d'Amato TA; Tung MY; Weyant RJ; Landreneau RJ
Ann Surg Oncol; 2001; 8(1):72-9. PubMed ID: 11206229
[TBL] [Abstract][Full Text] [Related]
9. Vascular endothelial growth factor, platelet-derived endothelial cell growth factor and angiogenesis in non-small-cell lung cancer.
O'Byrne KJ; Koukourakis MI; Giatromanolaki A; Cox G; Turley H; Steward WP; Gatter K; Harris AL
Br J Cancer; 2000 Apr; 82(8):1427-32. PubMed ID: 10780522
[TBL] [Abstract][Full Text] [Related]
10. Interleukin-8 messenger ribonucleic acid expression correlates with tumor progression, tumor angiogenesis, patient survival, and timing of relapse in non-small-cell lung cancer.
Yuan A; Yang PC; Yu CJ; Chen WJ; Lin FY; Kuo SH; Luh KT
Am J Respir Crit Care Med; 2000 Nov; 162(5):1957-63. PubMed ID: 11069840
[TBL] [Abstract][Full Text] [Related]
11. Thrombospondins I and II messenger RNA expression in lung carcinoma: relationship with p53 alterations, angiogenic growth factors, and vascular density.
Fontanini G; Boldrini L; Calcinai A; Chinè S; Lucchi M; Mussi A; Angeletti CA; Basolo F; Bevilacqua G
Clin Cancer Res; 1999 Jan; 5(1):155-61. PubMed ID: 9918214
[TBL] [Abstract][Full Text] [Related]
12. The intratumoral expression of vascular endothelial growth factor and interleukin-8 associated with angiogenesis in nonsmall cell lung carcinoma patients.
Masuya D; Huang C; Liu D; Kameyama K; Hayashi E; Yamauchi A; Kobayashi S; Haba R; Yokomise H
Cancer; 2001 Nov; 92(10):2628-38. PubMed ID: 11745198
[TBL] [Abstract][Full Text] [Related]
13. Thymidine phosphorylase and vascular endothelial growth factor in patients with Stage I lung adenocarcinoma.
Kojima H; Shijubo N; Abe S
Cancer; 2002 Feb; 94(4):1083-93. PubMed ID: 11920479
[TBL] [Abstract][Full Text] [Related]
14. Angiogenesis correlates with vascular endothelial growth factor expression but not with Ki-ras oncogene activation in non-small cell lung carcinoma.
Tsao MS; Liu N; Nicklee T; Shepherd F; Viallet J
Clin Cancer Res; 1997 Oct; 3(10):1807-14. PubMed ID: 9815567
[TBL] [Abstract][Full Text] [Related]
15. Significance of vascular endothelial growth factor messenger RNA expression in primary lung cancer.
Ohta Y; Endo Y; Tanaka M; Shimizu J; Oda M; Hayashi Y; Watanabe Y; Sasaki T
Clin Cancer Res; 1996 Aug; 2(8):1411-6. PubMed ID: 9816315
[TBL] [Abstract][Full Text] [Related]
16. Expression of vascular endothelial growth factor mRNA in non-small-cell lung carcinomas.
Fontanini G; Boldrini L; Chinè S; Pisaturo F; Basolo F; Calcinai A; Lucchi M; Mussi A; Angeletti CA; Bevilacqua G
Br J Cancer; 1999 Jan; 79(2):363-9. PubMed ID: 9888482
[TBL] [Abstract][Full Text] [Related]
17. The angiopoietins, tie2 and vascular endothelial growth factor are differentially expressed in the transformation of normal lung to non-small cell lung carcinomas.
Wong MP; Chan SY; Fu KH; Leung SY; Cheung N; Yuen ST; Chung LP
Lung Cancer; 2000 Jul; 29(1):11-22. PubMed ID: 10880843
[TBL] [Abstract][Full Text] [Related]
18. Vascular endothelial growth factor/KDR activated microvessel density versus CD31 standard microvessel density in non-small cell lung cancer.
Koukourakis MI; Giatromanolaki A; Thorpe PE; Brekken RA; Sivridis E; Kakolyris S; Georgoulias V; Gatter KC; Harris AL
Cancer Res; 2000 Jun; 60(11):3088-95. PubMed ID: 10850461
[TBL] [Abstract][Full Text] [Related]
19. Nitric oxide synthase, cyclooxygenase 2, and vascular endothelial growth factor in the angiogenesis of non-small cell lung carcinoma.
Marrogi AJ; Travis WD; Welsh JA; Khan MA; Rahim H; Tazelaar H; Pairolero P; Trastek V; Jett J; Caporaso NE; Liotta LA; Harris CC
Clin Cancer Res; 2000 Dec; 6(12):4739-44. PubMed ID: 11156228
[TBL] [Abstract][Full Text] [Related]
20. Vascular endothelial growth factor and osteopontin in stage I lung adenocarcinoma.
Shijubo N; Uede T; Kon S; Maeda M; Segawa T; Imada A; Hirasawa M; Abe S
Am J Respir Crit Care Med; 1999 Oct; 160(4):1269-73. PubMed ID: 10508818
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
